Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06262191 · ClinicalTrials.gov registry record · Early Phase 1
Testing an Adjustable Ankle Orthosis During Walking in Cerebral Palsy
A Early Phase 1 study of Cerebral Palsy, sponsored by Northern Arizona University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT06262191: Completed Early Phase 1 study of Cerebral Palsy, sponsored by Northern Arizona University.
NCT06262191 is a Early Phase 1 study of Cerebral Palsy that has completed, run by Northern Arizona University. The registered enrollment target is 11 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06262191, a Early Phase 1 study of Cerebral Palsy, has completed, sponsored by Northern Arizona University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to determine how an adjustable stiffness ankle braces affects walking performance and biomechanics in cerebral palsy.
Primary Outcome
Change in integrated soleus electromyography (mV/mV) muscle activity during stance phase of walking.
Conditions Studied
Interventions
- DEVICE Differential and adjustable stiffness AFO (DAS-AFO)
Study Locations (1)
Arizona
- Northern Arizona University - Flagstaff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2024-06-01 |
| Phase | Early Phase 1 |
What the finished NCT06262191 record still lists
NCT06262191 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Differential and adjustable stiffness AFO (DAS-AFO) is the first listed.
NCT06262191 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06262191 about?
NCT06262191 is a clinical study titled "Testing an Adjustable Ankle Orthosis During Walking in Cerebral Palsy". This study seeks to determine how an adjustable stiffness ankle braces affects walking performance and biomechanics in cerebral palsy.
What is the current status of trial NCT06262191?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2024-05-01. Estimated completion is 2024-06-01.
What conditions does trial NCT06262191 study?
This clinical trial studies the following conditions: Cerebral Palsy.
What interventions are being tested in trial NCT06262191?
The interventions under investigation include: Differential and adjustable stiffness AFO (DAS-AFO) (DEVICE).
Who is sponsoring clinical trial NCT06262191?
This trial is sponsored by Northern Arizona University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06262191 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06262191's enrollment target sits among peer trials
11 80th of 91 higher than 12 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy
RECRUITING · Early Phase 1
-
Adapted High-Intensity Virtual Reality Exergaming
ACTIVE NOT RECRUITING · Early Phase 1
-
Evaluating Wearable Robotic Assistance on Gait
COMPLETED · Early Phase 1
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI